OncoNano Medicine Announces Positive Preclinical Data for ONM-501 at AACR Virtual Conference on Tumor Immunology…
Read More
OncoNano Medicine to Present at The American Association for Cancer Research Virtual Conference on Tumor…
OncoNano Medicine Announces Expanded Research Collaboration with UT Southwestern Medical Center to Advance Development of…
SOUTHLAKE, Texas – September 20, 2021 – OncoNano Medicine, Inc. today announced an oral presentation...
Read More
July 19, 2021 SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced a presentation at the 2nd Annual LifeSci…
Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for…
SOUTHLAKE, Texas – August 27, 2019 – OncoNano Medicine, Inc. today announced that it has…
Southlake, TX. – June 26, 2020 – OncoNano Medicine, Inc. announced today the publication of…
– UTSW scientists demonstrate that a novel pH-sensitive polymer prolongs STING-mediated activation of innate immunity against…
- UTSW scientists demonstrate that a novel pH-sensitive polymer prolongs STINGmediated activation of innate immunity...
Read More